Is your child currently experiencing Crohn’s disease flare-ups? Local clinical research is testing a potential new medication to see if it may reduce weight loss, persistent diarrhea, rectal pain, chronic fatigue, and/or liver disease associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for 2 to 17 years old to join a Crohn’s disease medical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or CD and UC (including associated symptoms such as abdominal cramps, persistent diarrhea, abdominal pain, frequent fevers and/or anemia), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing gastrointestinal disease flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce cramping, blood in the stool, cramps, weight loss, and/or eye pain associated with gastrointestinal disease.
If you’re concerned about how gastrointestinal disease affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for 2 to 17 years of age to join a trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or IBD (including associated symptoms such as diarrhea, stomach pain, constant need to poop, weight loss and/or eye pain), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing moderate to severe IBD flare-ups? Local research study is testing a potential new medication to see if it may reduce abdominal cramps, stomach pain, cramps, frequent fevers, and/or joint pain associated with moderate to severe IBD.
If you’re concerned about how moderate to severe IBD affects your child’s life, find out more about the research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for 2 to 17 years of age to join a CD clinical trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe UC (including associated symptoms such as recurrent diarrhea, mouth sores, rectal pain, frequent fevers and/or eye pain), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce cramping, abdominal cramps, rectal pain, frequent fevers, and/or anemia associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for young people at least 2 years of age but under 18 to join a CD study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or Crohn’s disease (CD) (including associated symptoms such as diarrhea with pus, kidney stones, diarrhea, weight loss and/or joint pain), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing IBD flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce urgency to defecate, joint pain, diarrhea, weight loss, and/or eye pain associated with IBD.
If you’re concerned about how IBD affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for children aged 2 to 17 years to join a clinical research to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or moderately to severely active IBD (including associated symptoms such as painful joints, kidney stones, cramps, frequent fevers and/or anemia), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.